Chengdu Kanghua Biological Products Cash Flow Conversion Efficiency

Latest as of September 2025: 0.026x

Chengdu Kanghua Biological Products cash flow conversion efficiency. Based on the latest financial reports, Chengdu Kanghua Biological Products (300841) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥92.89 Million ≈ $13.59 Million USD) by net assets (CN¥3.51 Billion ≈ $513.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Chengdu Kanghua Biological Products (2015–2024)

Cash flow conversion efficiency of Chengdu Kanghua Biological Products from 2015 to 2024. This chart illustrates how Chengdu Kanghua Biological Products's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Chengdu Kanghua Biological Products stock price for real-time trading data and today's change.

Chengdu Kanghua Biological Products Cash Flow Conversion Ratio Explained

Chengdu Kanghua Biological Products cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Chengdu Kanghua Biological Products Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chengdu Kanghua Biological Products ranked by their cash flow conversion efficiency. Also see 300841 market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
BlackRock Technology and Private Equity Term Trust NYSE:BTX	-0.007x
Berliner Effektengesellschaft AG F:BFV	N/A
Xining Special Steel Co Ltd SHG:600117	-0.005x
Suzhou Recodeal Interconnect System Co Ltd SHG:688800	0.058x
Hengbao Co Ltd SHE:002104	0.011x
Uniphar Group PLC IR:UPR	-0.017x
Mcmillan Shakespeare Ltd AU:MMS	-0.294x
Elders Ltd AU:ELD	0.054x

Annual Cash Flow Conversion Efficiency for Chengdu Kanghua Biological Products (2015–2024)

The table below shows the annual cash flow conversion efficiency of Chengdu Kanghua Biological Products from 2015 to 2024. Review cash generation quality of Chengdu Kanghua Biological Products to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.45 Billion ≈ $504.48 Million	CN¥572.24 Million ≈ $83.74 Million	0.166x	+1.62%
2023-12-31	CN¥3.51 Billion ≈ $514.22 Million	CN¥573.98 Million ≈ $83.99 Million	0.163x	+157.64%
2022-12-31	CN¥3.08 Billion ≈ $450.07 Million	CN¥194.99 Million ≈ $28.53 Million	0.063x	+29.90%
2021-12-31	CN¥2.67 Billion ≈ $390.75 Million	CN¥130.33 Million ≈ $19.07 Million	0.049x	-73.93%
2020-12-31	CN¥1.97 Billion ≈ $288.92 Million	CN¥369.56 Million ≈ $54.08 Million	0.187x	-41.14%
2019-12-31	CN¥574.65 Million ≈ $84.09 Million	CN¥182.73 Million ≈ $26.74 Million	0.318x	+103.86%
2018-12-31	CN¥367.70 Million ≈ $53.81 Million	CN¥57.35 Million ≈ $8.39 Million	0.156x	-67.34%
2017-12-31	CN¥188.37 Million ≈ $27.56 Million	CN¥89.96 Million ≈ $13.16 Million	0.478x	+1838.25%
2016-12-31	CN¥-96.21 Million ≈ $-14.08 Million	CN¥2.64 Million ≈ $386.80K	-0.027x	+56.55%
2015-12-31	CN¥-102.87 Million ≈ $-15.05 Million	CN¥6.51 Million ≈ $951.92K	-0.063x	--

About Chengdu Kanghua Biological Products

SHE:300841 China Biotechnology

Market Cap

$951.72 Million

CN¥6.50 Billion CNY

Market Cap Rank

#8772 Global

#2033 in China

Share Price

CN¥50.05

Change (1 day)

+2.29%

52-Week Range

CN¥42.86 - CN¥84.21

All Time High

CN¥399.08